SEC Form 4 · accession 0001209191-18-028866
CAMBREX CORP · CBM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Sargen
Officer — EVP, Corporate Development
Period of report
May 7, 2018
Accepted (ET)
May 9, 2018 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000820081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 7, 2018 | A | 30,000 | $0.00 | A | 50,000 | D | |
| Common StockF2,F3 | May 7, 2018 | S | 23,002 | $49.4618 | D | 26,998 | D | |
| Common Stock | May 8, 2018 | A | 7,500 | $16.905 | A | 34,498 | D | |
| Common Stock | May 8, 2018 | A | 7,500 | $17.81 | A | 41,998 | D | |
| Common Stock | May 8, 2018 | A | 15,000 | $41.36 | A | 56,998 | D | |
| Common Stock | May 8, 2018 | A | 7,500 | $40.65 | A | 64,498 | D | |
| Common StockF4 | May 8, 2018 | S | 10,565 | $49.05 | D | 53,933 | D | |
| Common StockF5 | May 8, 2018 | S | 33,933 | $49.6254 | D | 20,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $16.905 | May 8, 2018 | M | 7,500 | A | — | Oct 28, 2020 | Common Stock | 7,500 | 0 | D |
| Stock Option (right to buy)F7 | $17.81 | May 8, 2018 | M | 7,500 | A | — | Oct 22, 2021 | Common Stock | 7,500 | 7,500 | D |
| Stock Option (right to buy)F8 | $41.36 | May 8, 2018 | M | 15,000 | A | — | Oct 21, 2022 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (right to buy)F9 | $40.65 | May 8, 2018 | M | 7,500 | A | — | Oct 26, 2023 | Common Stock | 7,500 | 22,500 | D |
Explanation of responses
- F1Pursuant to settlement of a performance share award.
- F2Broker-assisted sale of which 14,805 shares were to cover the payment of withholding tax liability from the settlement of a performance share award.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.20 to $49.875 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 3 to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.50 to $49.45 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 4 to this Form 4.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $49.85 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 5 to this Form 4.
- F6The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted.
- F7The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted.
- F8The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 22, 2016, which was the first anniversary of the date on which the option was granted.
- F9The option representing a right to purchase 30,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted.